Wakabayashi Yusuke, Nakai Noriaki, Takenaka Hideya, Katoh Norito
Department of Dermatology, Kyoto Prefectural University of Medicine Graduate School of Medical Science, Japan.
Acta Dermatovenerol Croat. 2012;20(4):263-6.
Superficial acral fibromyxoma (SAF) is a rare, distinctive, benign soft tissue tumor with a predilection for the hands and feet, first described by Fetsch et al. in 2001. Histologically, SAF tumors are unencapsulated, mostly located in the dermis or subcutis, and composed of spindled and stellate-shaped cells with random, loose storiform and fascicular growth patterns. The stromal component of the tumor was Alcian blue-positive. The tumor cells were mostly immunopositive for CD34, vimentin, and CD99; often immunopositive for EMA; and immunonegative for S-100, HMB-45, SMA, desmin, and keratin. There have been 19 reports of 149 SAF cases in the English language literature. However, SAF is not widely recognized because it is an uncommon occurrence that has been described only relatively recently. Herein, we report a case of SAF and describe the clinicopathologic characteristics based on a review of published SAF cases from July 2001 to July 2011.
浅表性肢端纤维黏液瘤(SAF)是一种罕见的、独特的良性软组织肿瘤,好发于手足部,于2001年由费奇等人首次描述。组织学上,SAF肿瘤无包膜,大多位于真皮或皮下组织,由梭形和星状细胞组成,呈随机、疏松的席纹状和束状生长模式。肿瘤的间质成分阿利新蓝染色呈阳性。肿瘤细胞大多对CD34、波形蛋白和CD99免疫阳性;常对EMA免疫阳性;对S-100、HMB-45、平滑肌肌动蛋白、结蛋白和角蛋白免疫阴性。英文文献中有19篇报道了149例SAF病例。然而,SAF并未得到广泛认可,因为它是一种罕见疾病,且直到最近才被描述。在此,我们报告1例SAF病例,并通过回顾2001年7月至2011年7月已发表的SAF病例来描述其临床病理特征。